These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 17111390)
1. Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum glucose and prediction of nodal status in non-small cell lung cancer. Akhurst T J Surg Oncol; 2006 Dec; 94(7):547-8. PubMed ID: 17111390 [No Abstract] [Full Text] [Related]
2. Standard uptake value predicts survival in non-small cell lung cancer. Okereke IC; Gangadharan SP; Kent MS; Nicotera SP; Shen C; DeCamp MM Ann Thorac Surg; 2009 Sep; 88(3):911-5; discussion 915-6. PubMed ID: 19699919 [TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814 [TBL] [Abstract][Full Text] [Related]
4. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study. Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786 [TBL] [Abstract][Full Text] [Related]
6. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer. Li M; Liu N; Hu M; Shi F; Yuan S; Zhang P; Fu Z; Yang G; Yu J Lung Cancer; 2009 Mar; 63(3):383-6. PubMed ID: 18635284 [TBL] [Abstract][Full Text] [Related]
7. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098 [TBL] [Abstract][Full Text] [Related]
8. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. Hara T; Inagaki K; Kosaka N; Morita T J Nucl Med; 2000 Sep; 41(9):1507-13. PubMed ID: 10994730 [TBL] [Abstract][Full Text] [Related]
9. Consideration of serum glucose levels during malignant mediastinal lymph node detection in non-small-cell lung cancer by FDG-PET. Lee WW; Chung JH; Jang SJ; Eo JS; Park SY; Sung SW; So Y; Chung JK; Lee MC; Kim SE J Surg Oncol; 2006 Dec; 94(7):607-13. PubMed ID: 17039492 [TBL] [Abstract][Full Text] [Related]
10. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Steinert HC; Hauser M; Allemann F; Engel H; Berthold T; von Schulthess GK; Weder W Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071 [TBL] [Abstract][Full Text] [Related]
11. Radioguided detection of lymph node metastasis in non-small cell lung cancer. Nwogu C; Fischer G; Tan D; Glinianski M; Lamonica D; Demmy T Ann Thorac Surg; 2006 Nov; 82(5):1815-20; discussion 1820. PubMed ID: 17062254 [TBL] [Abstract][Full Text] [Related]
12. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer. Nishiyama Y; Yamamoto Y; Kimura N; Ishikawa S; Sasakawa Y; Ohkawa M Ann Nucl Med; 2008 May; 22(4):245-50. PubMed ID: 18535874 [TBL] [Abstract][Full Text] [Related]
13. Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography. Dooms C; Verbeken E; Stroobants S; Nackaerts K; De Leyn P; Vansteenkiste J J Clin Oncol; 2008 Mar; 26(7):1128-34. PubMed ID: 18309948 [TBL] [Abstract][Full Text] [Related]
14. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer. Sachs S; Bilfinger TV; Komaroff E; Franceschi D Clin Lung Cancer; 2005 Mar; 6(5):310-3. PubMed ID: 15845183 [TBL] [Abstract][Full Text] [Related]
15. Sentinel node and positron emission tomography mapping in lung cancer. Nwogu C Semin Thorac Cardiovasc Surg; 2009; 21(4):323-6. PubMed ID: 20226345 [TBL] [Abstract][Full Text] [Related]
16. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients]. Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282 [TBL] [Abstract][Full Text] [Related]
17. FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls. Vansteenkiste JF Lung Cancer; 2005 Feb; 47(2):151-3. PubMed ID: 15639713 [No Abstract] [Full Text] [Related]
18. The standardize uptake value: light and shade of positron emission tomography. Bertolaccini L; Rizzardi G; Terzi A; Bianchi A Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):969. PubMed ID: 21659322 [No Abstract] [Full Text] [Related]
19. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Bryant AS; Cerfolio RJ; Klemm KM; Ojha B Ann Thorac Surg; 2006 Aug; 82(2):417-22; discussion 422-3. PubMed ID: 16863739 [TBL] [Abstract][Full Text] [Related]
20. Use of anthropometric factors in 18F-FDG PET bone marrow SUVs. Thie JA J Nucl Med; 2006 Nov; 47(11):1901-2; author reply 1902. PubMed ID: 17079825 [No Abstract] [Full Text] [Related] [Next] [New Search]